BioMarin Pharmaceutical, Inc.
(NASDAQ : BMRN)

( )
BMRN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.00%204.730.0%$1981.02m
NVAXNovavax, Inc. 0.00%110.8278.2%$792.93m
BIIBBiogen, Inc. 0.00%239.301.8%$522.63m
AMGNAmgen, Inc. 0.00%235.361.4%$522.04m
BNTXBioNTech SE 0.00%196.000.0%$501.82m
GILDGilead Sciences, Inc. 0.00%71.771.0%$472.12m
ILMNIllumina, Inc. 0.00%405.143.3%$406.87m
REGNRegeneron Pharmaceuticals, Inc. 0.00%615.242.7%$388.21m
VRTXVertex Pharmaceuticals, Inc. 0.00%234.061.9%$331.63m
SNSSSunesis Pharmaceuticals, Inc. 0.00%3.170.7%$221.59m
EXASEXACT Sciences Corp. 0.00%78.4317.9%$151.61m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%148.508.2%$151.18m
ARNAArena Pharmaceuticals, Inc. 0.00%92.6513.7%$144.29m
INCYIncyte Corp. 0.00%74.882.4%$128.10m
BBIOBridgeBio Pharma, Inc. 0.00%12.750.0%$115.66m

Company Profile

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.